A Toxic STING-Samhd1 Axis Drives Replication Stress In Progeria And Cancer Cells

Aging Theory
Aging Pathway
Therapeutic
A newly identified harmful interaction between the STING and SAMHD1 proteins causes problems with DNA replication and genetic instability in cells from individuals with progeria and in cancer cells.
Author

Gemini

Published

June 19, 2026

Our cells are constantly copying their DNA, a vital process called replication. Sometimes, this process encounters roadblocks, leading to “replication stress,” which can cause errors and damage to our genetic material. This stress is a hallmark of both premature aging diseases, like Hutchinson-Gilford Progeria Syndrome, and various cancers.

Recent research has uncovered a critical interaction between two proteins, STING and SAMHD1, that drives this replication stress. STING is typically known for its role in the immune system, where it detects foreign DNA and triggers protective responses. However, in progeria cells, and certain cancer cells, STING accumulates in the cell’s nucleus, the compartment housing our DNA, and directly interferes with DNA replication. This interference causes the DNA copying machinery to slow down and even stall.

Adding to this complexity is SAMHD1, a protein that normally helps maintain the correct balance of DNA building blocks (called dNTPs) and assists in DNA repair. The study reveals that STING’s detrimental effects on DNA replication, including the depletion of these essential dNTPs and the resulting DNA damage, are actually carried out through SAMHD1. Essentially, STING and SAMHD1 form a “toxic axis” that severely disrupts DNA replication and leads to genomic instability, a state where the cell’s genetic material becomes prone to mutations and rearrangements.

Understanding this harmful partnership between STING and SAMHD1 opens new avenues for therapeutic development. By targeting either of these proteins, scientists hope to alleviate replication stress and improve genomic stability, potentially offering new treatment strategies for progeria and certain cancers.


Source: link to paper